Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Use Arnold but call it "Total Recall"
My vote is for Synap-to-it.
I'd say by end of next week.
I've changed my mind. I've done my own TA. I've used my set of tools, and I have really crunched the numbers. I see a definite trend developing in the recent price action.
I am very comfortable that we could see a move to around $5, possibly as high as $6.
On the other hand, depending on the support we see or the resistance, we could be taken down to $4, perhaps as low as $3.
What I recommend is to buy when it goes down and sell when it goes up.
Today's action was an easily anticipated, nearly meaningless event.
All the the gains that have been had right now by "playing" the ups and downs...
Compared with what someone would gain by just going Long and standing pat..
In the end will amount to a fraction of a percent difference. That is, if a day-trader has the sense and luck to be all in on the day the real pop happens.
There was no "giant pop". There was a modest rise this morning followed by profit taking.
A giant pop is coming shortly though. And it won't retrace afterward.
I feel very strongly that we are going to see more PR's this week. Most notably, we should see a PR on Thursday regarding the presentation on the 11th.
What will it contain??? HUGE question. It could have PK/PD, extension update, MTA update, partnership/licensing news... maybe nothing. Maybe no PR for all I know. But there is definitely a possibility.
I agree... but it is certainly interesting that this statement is very different from the way it has been phrased in past PR's.
For instance, in the Aug 7th PR:
""We are entering the second half of 2017 with our strongest balance sheet to date, which allows the Company to execute the Phase 2 clinical trial in Rett syndrome, for which ANAVEX™ 2-73 has been granted Orphan Drug Designation by the FDA, as well as the Phase 2/3 clinical trial in Alzheimer’s disease and the Phase 2 clinical trial in Parkinson’s disease,” said Christopher U. Missling"
They very carefully laid out their plans in this PR. Seems funny to me that they would mash it all together today in the PR.
Could be nothing, but perhaps not.
Keep your eyes open for new developments!!
The way this sentence is worded is very interesting. It almost seems like it may be saying that the trials for the other indications will be phase 2/3 as well.
Good thing the proof you look for will be sought (and IMO obtained) within months. Then you will be convinced.
I agree with you then. As you say, BIIB thinks 2-73 could work and they want to be first in line to make a deal with AVXL.
Not entirely correct. The full reason is because they thought it could work AND they want to be first in line with AVXL if their tests duplicate the results. That is the most important part of the reason. And it is undeniable.
Glad to see the BIIB has less of a pessimistic approach to 2-73. They jumped right in and started conforming what a 3rd party had already proven. They are doing testing for one reason... they are looking to buy/partner with AVXL.
I'm not saying that they have made a decision yet... but it is undeniable that they are interested.
Either that or else you think that they decided to run some tests just to help out their young competitor.
News will be great. Twist it however you like.
News is a 100% lock for next week.
As long as we're talking about A2-73's effects...
It also causes BIIB to enter into an MTA with tiny AVXL. This is proof that it has their (BIIB's) attention. Any indication from BIIB that they were happy/impressed/satisfied with the results they saw in their confirmatory testing will be met by a long, sustained buying frenzy.
I mean, if you drove by a car lot and something catches your eye...that's fine. If you stop and chat with the dealer... that's better. But when you take it for a test drive and have your mechanic give it a once over... that's different. Next thing you know, your talking to Chris from Financing.
Maybe they already talked to Chris.
He has bought every Monday...
that's not happening next week...
Hmmmm...
It matches what he did last week. Two weeks in a row now where he has bought Monday and Thursday.
We absolutely should see a PR about the patent by Tuesday. Hopefully there is more coming quickly thereafter or even at the same time.
Everything doesn't happen all at once. Patience is required.
Things are obviously happening. Rett is ramping up. Conferences coming up. Data soon to be released. Patent issuance eminent. There are things that need to happen in a certain order.
I understand wanting to get on with it, but calling out the CEO as derelict is uncalled for.
It may be taking longer than you thought it should, and that is fine. It will take as long as it takes.
PATIENCE.
Patent isn't issued yet. It is standard behavior for a company to wait until issuance before PR'ing the patent.
I knew you would come around.
;)
I think you and I are pretty close on developments expected this year. With all this I see us in the $15-$20 range by years end.
Once Rett trial data comes out all bets are off though.
Awesome explanation for the nuts and bolts of Rett Syndrome.
How ironic... Anavex, a company dedicated to restoring cognitive function, is about to "blow all our minds".
Rett results is the first "scheduled" catalyst that I feel could take us off the charts. Of course, that's not considering unknown catalysts that could come up in the meantime.
What pps will we see by the end of the year IYO?
Vaccinations are not mandated to reduce costs. There are social considerations when talking about communicable diseases. Vaccinations are required (although, not really required unless attending public school) to protect public health.
I've got a sneaking suspicion that we might get just that. Maybe the PK/PD. Maybe a 104-week extension update. Maybe both.
Going to be a huge 4-day week IMO.
Not to throw cold water on such good conversation. (Which sounds like music to my ears by the way)
Aren't we getting just a tad ahead of ourselves? I mean, why don't we get to $10 first. Then we can start thinking about $1000+ for goodness sake.
Personally I would be ecstatic to see a run up to $15+ by the end of the year. Anything above that would be insanely good.
The NOVA documentary was very eye-opening. They showed how people show plaque buildup usually in their 40's but don't develop dementia till years later.
AVXL may be able to nip it in the bud.
Go to the patent website:
https://portal.uspto.gov/pair/PublicPair
Once you prove you're not a computer select "control number" and search for this number:
13/940352
Then click on "Assignments" tab. Then look in the upper right corner of the page and you see the issue date of the patent.
9/5/17
We should get an PR on either 9/5 or 9/6. I'd guess 9/5.
Going to be a huge 4-day week!!!
I've said all along that I think the patent will start everything off as far as PR's go. The patent should be final final final by around this Friday. Give it take a couple days. My guess is that we should get PR announcement this Friday or next Tuesday.
IMO.
I've said all along that I think the patent will start everything off as far as PR's go. The patent should be final final final by around this Friday. Give it take a couple days. My guess is that we should get PR announcement this Friday or next Tuesday.
IMO.
Maybe it will be reported tomorrow. That's what happened last week. He bought Thursday but the News didn't come out till Friday.
I agree, but only because there are so many people that buy into the idea. That's why I say it's a self fulfilling prophecy.
A person I am acquainted with is a TA guy. Here's an example of his "predictions" on where we could go from here:
3.80
3.90
4.00
4.12
4.00-4.10
4.25-4.30
4.30-4.35
4.50
4.75
...and my favorite...
4.25-6.25
TA has a use. It shows us where the people who believe in TA think it is going to go. That's it. Nothing more.
There is no mathematical reason for the movements of the market other than $$$$$. It doesn't have "a mind of its own". It doesn't need to do anything other than what buyers and sellers want to do a a certain moment.
It's a game of smoke and mirrors, self-fulfilling prophecies.
Just take a look in the "news" tab on ihub.
Looking forward to it!
Do you think we will see any change in the pattern this week? 375 shares Monday and Friday?
Should see significant news this week or next I assume.
We should see the PR for the patent on Friday or the following Monday. IMO.
It wouldn't surprise me either. Especially with all the changes happening right now in the FDA. Maybe it's a wrong idea. I would never promote an assumption I am making as fact. Time will tell though.
Looking forward to (hopefully) awesome news soon.